A Convergence of Chemistry And Biology To Create Better Medicine

Learn More
About AmbrxAbout Ambrx
Product PipelineProduct Pipeline
Our TechnologyOur Technology

News

Ambrx closes $45M round of financing

SAN DIEGO, Aug. 4, 2016 /PRNewswire/ -- Ambrx, Inc., a clinical stage biotechnology company that discovers and develops first-in-class and best-in-class optimized protein...